Clinical Audit of Heart Rhythm Devices Pacemaker, ICD and CRT South West London Cardiac Network

Size: px
Start display at page:

Download "Clinical Audit of Heart Rhythm Devices Pacemaker, ICD and CRT South West London Cardiac Network"

Transcription

1 2011 Clinical Audit of Heart Rhythm Devices Pacemaker, ICD and CRT South West London Cardiac Network David Cunningham Senior Strategist, NICOR Morag Cunningham CRM Database Coordinator, NICOR Richard Charles Chairman, Heart Rhythm UK Device Audit Group

2 Acknowledgments The implant registration data that allows the construction of reports such as this is contributed on a voluntary basis by all pacemaker implanting hospitals in the United Kingdom. The data is held in the National Pacemaker Database, established in 1977 by Dr Anthony Rickards, and now part of the Central Cardiac Audit Database (CCAD) which runs the national cardiac audits as part of the National Institute for Cardiovascular Outcomes Research (NICOR), which is part of University College London. Anonymised extracts from the National Pacemaker Database were used to generate this report, with the express permission of the owners of the data, Heart Rhythm UK and the full agreement of the Department of Health Heart Team and HQIP. This national clinical audit is funded as part of the National Clinical Audit & Patient Outcome Programme (NCAPOP), which is managed by the Healthcare Quality Improvement Partnership (HQIP The preparation of this report was supported by HQIP. Data collection was carried out by NICOR with support provided from NHS Improvement ( and the Cardiac Networks. The study was performed with the knowledge and support of the British Cardiovascular Society and Heart Rhythm UK. Clinical review of the report was carried out by Dr Richard Charles, Chairman of the Heart Rhythm UK Audit Group. The report may be downloaded from

3 Contents Acknowledgments...2 Contents...3 Introduction to the 2011 Reports...4 The National Clinical Audit Report...5 Overview of Device Implants in the UK...7 How does the UK compare with Europe?...9 Data Quality Statement...14 Data Completeness and Data Quality for Key Hospitals in this Network Implant Rates in the Cardiac Networks...17 PCTs/LHBs in the Network...20 Correcting Implant Rates for Age and Sex...21 Relative Need for Pacemakers, ICDs and CRTs...23 Centres providing Device Implants to this Network Year Implant Trends Network v National...25 Provider Hospitals: which hospitals serve which PCTs/LHBs?...26 Geographical Location of Implants...30 Pacing Mode in this Network: Physiological vs Non-Physiological...32 Pacing Mode for New Implants by Centre...33 Physiological Pacing in Sick Sinus Syndrome...34 ECG Indication for New Pacemaker Implants...35 New Pacemaker Implant Rates corrected for Age and Sex...36 New ICD Implant Rates corrected for Age and Sex...37 New Implant Rate Maps...38 Pacemaker Implant Deficit in Conclusions

4 Introduction to the 2011 Reports The Heart Rhythm UK Device Audit Group (formerly the Network Devices Survey Group), now in its ninth consecutive year of work, continues its audit of cardiac rhythm management, and particularly the level of provision of cardiac pacemakers, implantable defibrillators and cardiac resynchronisation therapy in England and Wales. This year the seventh consecutive annual national report has been published, covering clinical activity in 2011, and it is a pleasure for me to welcome its publication. You will find the national report at The report s principal focus remains the provision of data on the total volume and equity of provision of implantable cardiac devices, corrected for the demographic structure of the population. The methodology allows valid comparison of activity between and within different Network areas, and thus benchmarking of activity. This year the audit has used population data from the 2011 census, rather than serial extrapolations from the 2001 census, which should be borne in mind when comparing implant activity in this report with those from previous years. A summary account of cardiac arrhythmia ablation activity is now a fixed and valuable section of the report, and one which will be developed further in future reports. Work over the past two years has resulted in this being a full clinical audit of cardiac rhythm management, having evolved from the more simple past surveys of implantable device activity. Completion of an increased number of data fields has been encouraging, and I congratulate all those involved, particularly cardiac physiologists, arrhythmia nurses and clinicians who have worked so hard to ensure data collection. Clinical audit lies at the heart of understanding the quality and effectiveness of what we do for patients, and our performance compared to national and professional guidelines. The report provides an excellent contemporary picture of cardiac device and arrhythmia ablation activity in the NHS in England and Wales. Enormous progress has been made, driven by the advances in clinical science and technology and the hard work of NHS staff who translate these advances into practice. There is always scope for improvement, and this report highlights that volumes and equity of service provision of arrhythmia services in the NHS sometimes falls short by international comparison. However, the progress made to date is encouraging and I commend this report to all colleagues who plan, commission or deliver cardiac arrhythmia services for patients in England and Wales. Professor Huon Gray Interim National Clinical Director for Cardiovascular Disease, Dept of Health (England) & Consultant Cardiologist, University Hospital of Southampton - 4 -

5 The National Clinical Audit Report The Heart Rhythm UK Device Audit Group (formerly the Network Device Survey Group) is pleased to present its seventh set of annual reports covering the calendar year Our name change is not a mere re-branding; consistent with the aspirations set out in my Introduction to the 2010 Report, it reflects our steady progress towards a full clinical audit, and our integral relationship with our national society. Furthermore, the transfer of the cardiac audits during 2011, including this device audit, to the aegis of NICOR (the National Institute for Cardiovascular Outcomes Research based at University College, London) has been a wholly positive development which will greatly enhance the probability that the audit will indeed survive, develop and flourish in future. Whilst it is crucial for us to expand the clinical outcomes content of the Audit report, it remains a vital task of this Report to present data describing the total volume and equity of provision of the major cardiac implantable device therapies pacemakers for bradycardia (PM), implantable cardioverter defibrillators (ICDs) for cardiac arrest and cardiac resynchronisation therapy (CRT) for advanced heart failure across all Cardiac Networks in England and Wales. The core methodology of the survey remains unchanged, allowing valid direct comparison between Cardiac Networks, Primary Care Trusts (Local Health Boards in Wales) and between the national reports for 2009, 2010, the current report for 2011, and all previous annual reports. A full account of the methodology is presented within the National Report. This report continues to use the current professionally accepted targets for each device class, as in previous years 700 new implants/million(m) population for PM, 100 new implants/m for ICD and 130 total (new + replacement)/m for CRT, although there is a compelling case to revisit these targets in the light of current European trends. UK performance must be viewed in the context of our European neighbours; as we have previously emphasised, there is evidence neither of over-prescribing of devices in Europe, nor is there evidence that the prevalence of the conditions for which a device is indicated, based on current professional guidelines, differs between the UK and Western Europe. What are the headline results for 2011? In England, the PM new implant rate is 525/M, a small fall from 2010 which establishes a disappointing flat line from The ICD new rate is 77/M, a 6.9% increase over 2010, whilst the CRT total rate is 113/M, marking an abrupt halt to the consistent year-on-year rise since The performance of the NHS in England continues to compare unfavourably with most of the developed European economies. Wales demonstrates striking and commendable increases in implant rates for PM and CRT, whilst falls in implant rates in Northern Ireland for ICD and CRT arrest its erstwhile progress, although the ICD implant rate there continues to far exceed the rest of the UK. Data returns from Scotland show signs of improvement for complex devices but remain sadly depleted, as in previous years. It can be emphasised with confidence that the overall provision of - 5 -

6 cardiac implantable devices by the NHS remains inadequate to meet the needs of the population at risk. Inequity of provision of devices still afflicts the NHS but has noticeably decreased due to a general regression towards the (inadequate) mean implant rate. A regression towards the target would have been more welcome. To spell it out yet again, your chances of getting the life saving or life enhancing device you need depends critically on where you live. The 2011 Reports continue our drive to present the clinical data which support the prescription of complex devices in particular. Finally, it is again a pleasure to recognise both the efforts of hard pressed clinical staff at implanting centres who submit their data and the continued input of constructive criticism from all who are charged with, and wish to see, the provision of a top class device service in the UK. To all colleagues we offer our thanks for their contribution to the resource we offer here. Dr Richard Charles Emeritus Consultant Cardiologist, Liverpool Heart and Chest Hospital Chairman, Heart Rhythm UK Audit Group The National Audit of Cardiac Rhythm Management 2011 Report can be downloaded from

7 Overview of Device Implants in the UK General note: up to 2010, population estimates were year-on-year projections from ONS of the population, extrapolating from the 2001 census. In general these projections tend to under-estimate the true population. The 2011 rates use the population from the 2011 census, so a slight increase in actual implant rate might be masked by replacing a population under-estimate with a true estimate. (Note: the rates in these graphs are NOT adjusted for age and sex). New Pacemakers Comments England Wales Scotland N Ireland Pacemaker implant rate in England again remains static (524 per million population). per million population Large increase in new pacemaker rate in Wales 100 No increase in pacing rate in N Ireland year Data submissions from Scotland have improved but are still incomplete. New ICDs Comments ICD rate fell slightly in N Ireland but is still well above the rest of the UK. England and Wales rates remain very similar, with a modest increase in per million population England Wales Scotland N Ireland Dramatic rise in Scottish rate actually reflects better data submission, but is still not 100% complete year - 7 -

8 Total CRTs Comments The total CRT rate (all implants CRT-P and CRT- D) for England failed to increase for the first year since these devices were introduced. per million population England Wales Scotland N Ireland There was a large increase in the CRT rate in Wales and a large drop in N Ireland year The CRT rate in Scotland remains very low and is one of the lowest in Europe

9 How does the UK compare with Europe? Pacemaker New Implant Rate 2011 per million population Germany Iceland France Italy Sweden Finland Estonia Malta Czech Republic Lithuania Denmark Belgium Switzerland Poland Norway Slovakia UK Greece Slovenia Croatia Portugal Latvia Netherlands Serbia San Marino Israel Bulgaria Montenegro Belarus Luxembourg Russia Macedonia Bosnia Herzegovina Armenia Ukraine Azerbaijan

10 ICD New Implant Rate 2011 per million population San Marino Czech Republic Germany Denmark Italy Poland Belgium Norway Netherlands Slovakia Switzerland Finland France Israel Sweden Luxembourg Iceland Portugal UK Greece Spain Estonia Malta Montenegro Serbia Lithuania Latvia Belarus Bosnia Herzegovina Macedonia Bulgaria Armenia Russia Georgia Ukraine

11 CRT Total Implant Rate 2011 per million population Italy Germany Denmark Czech Republic Netherlands France Austria UK San Marino Norway Sweden Hungary Switzerland Israel Poland Finland Slovakia Estonia Belgium Ireland Malta Spain Iceland Portugal Slovenia Serbia Luxembourg Greece Lithuania Latvia Montenegro Cyprus Bulgaria Croatia Romania Macedonia Tunisia Russia Bosnia Herzegovina Belarus Georgia Armenia Azerbaijan Egypt Ukraine Morocco

12 Comments and Analysis of UK Implant Rates compared to Europe UK device implant rates have lagged behind our European neighbours for decades. The situation is not improving, it is getting worse. It is clear from the graphs above that small countries with a low GDP cannot afford to implant cardiac devices. The UK is not in that situation. To compare like with like, we took an average of European countries with a population over 10 million and a GDP per capita of at least $10,000 in The nine countries selected for comparison were Netherlands, Germany, France, Belgium, Italy, Spain, Portugal, Greece and the Czech Republic. The table below shows the UK implant rates and the population-weighted European average rates. UK 2011 Europe 2011 Pacemaker new implant rate ICD new implant rate CRT total implant rate Clearly there remains an enormous deficit in new implant rates for pacemakers and ICDs. The target (set some years ago) of 700 new implants per million for pacemakers seems to be still valid in comparison with Europe. However, the target of 100 for new ICD implants appears low in comparison with Europe, although still much higher than the UK is currently achieving. The European average CRT rate is 10% higher than the Heart Rhythm UK/BSH target rate of 130 and so this target probably does not need to be reviewed at the moment. All data in this section was extracted from the EHRA White Book 2012: The Current Status of Electrophysiology in ESC Member Countries. The book can be found at ehra-white-book-2012.pdf

13 New Pacemaker Implant Rate Europe

14 Data Quality Statement The quality of the analyses in this report is only as good as the quality of the data on which it is based. That data is originally submitted by hospitals to the National Pacemaker Database. If there is a deficit in registration, or if registrations do not contain a valid postcode, then analysis gaps are inevitable. Data is then anonymised and extracted to provide the basis of this analysis. To minimise the risk of deficit errors, a threshold of 98% for registration and postcode completeness is sought for each hospital. Overall network completeness must reach 98% or a report will not be issued. Every effort is made to ensure this report is as accurate as possible - however please contact us if you identify any residual problem and we will try to correct the error promptly

15 Data Completeness and Data Quality for Key Hospitals in this Network Listed below are the most important data fields and their completion rates with CLINICALLY VALID entries. Note that any code which translates to Unknown or Uncoded is not considered to be clinically valid. Please note Mayday University Hospital has been renamed Croydon University Hospital

16 - 16 -

17 2011 Implant Rates in the Cardiac Networks There has been a noticeable decrease in variability across networks in This has resulted from a decrease in rate for the highest rate implanting networks and an increase in the lower rate networks. Unfortunately this means that none of the networks now implant up to the target rate of 700 for pacemakers. It would have been preferable to see regression towards the target rather than regression towards the mean. As it stands, it appears that a clinically inadequate national average is being sought as an acceptable level of performance, when the focus should be on improvement to the levels of our Western European neighbours. The grey line represents the national average rate. The blue line is the national target rate. new Pacemaker rate 2011 adjusted for age and sex North West London Cardiac and Stroke Network Dorset Cardiac Network Sussex Heart Network North & East Yorkshire and Northern Lincolnshire Cardiac Network Bedfordshire and Hertfordshire Heart and Stroke Network North East London Cardiac and Stroke Network South West London Cardiac Network North Central London Cardiac & Stroke Network North of England Cardiovascular Network Kent Cardiovascular Network Cheshire & Merseyside Cardiac Network Anglia Stroke and Heart Network South Central Cardiovascular Network West Yorkshire Cardiac Network Greater Manchester & Cheshire Cardiac Network North Trent Network of Cardiac Care Surrey Heart & Stroke Network Black Country Cardiovascular Network Birmingham, Sandwell and Solihull Cardiac and Stroke Network Peninsula Cardiac Managed Clinical Network East Midlands Cardiac & Stroke Network Cardiac and Stroke Networks in Lancashire and Cumbria Avon, Gloucestershire, Wiltshire & Somerset Cardiac and Stroke Network South East London Cardiac & Stroke Network Essex Cardiac and Stroke Network South Wales North Wales Shropshire & Staffordshire Cardiac Network NB: North Wales and South Wales have a higher than average need for pacing so the adjusted rates shown here are lower than the unadjusted national rate for Wales shown on Page 7. Coventry & Warwickshire Cardiovascular Network Herefordshire and Worcestershire Cardiac Network The national target rate is 700 implants per million population. No network reaches this level

18 ICD The grey line represents the national average rate. The blue line is the national target rate. new ICD rate 2011 adjusted for age and sex North East London Cardiac and Stroke Network Dorset Cardiac Network Sussex Heart Network South West London Cardiac Network North West London Cardiac and Stroke Network Cheshire & Merseyside Cardiac Network North Central London Cardiac & Stroke Network Bedfordshire and Hertfordshire Heart and Stroke Network Surrey Heart & Stroke Network Kent Cardiovascular Network Black Country Cardiovascular Network West Yorkshire Cardiac Network Birmingham, Sandwell and Solihull Cardiac and Stroke Network East Midlands Cardiac & Stroke Network North & East Yorkshire and Northern Lincolnshire Cardiac Network North of England Cardiovascular Network Essex Cardiac and Stroke Network South Central Cardiovascular Network Avon, Gloucestershire, Wiltshire & Somerset Cardiac and Stroke Network North Wales South Wales Peninsula Cardiac Managed Clinical Network Anglia Stroke and Heart Network Greater Manchester & Cheshire Cardiac Network Shropshire & Staffordshire Cardiac Network Herefordshire and Worcestershire Cardiac Network Coventry & Warwickshire Cardiovascular Network South East London Cardiac & Stroke Network North Trent Network of Cardiac Care Cardiac and Stroke Networks in Lancashire and Cumbria Dorset and NE London are to be commended for maintaining their implant rates at or above the national target of 100. Sussex has seen a significant increase and has also reached the target, as has SW London. Hereford & Worcester has seen an improvement from an extremely low level (<40) to nearly 60. The rate in Lancs & Cumbria remains very low. For some reason the rate in SE London has fallen catastrophically, and this needs further examination

19 CRT The grey line represents the national average rate. The blue line is the national target rate. total CRT rate 2011 adjusted for age and sex Dorset Cardiac Network North West London Cardiac and Stroke Network Kent Cardiovascular Network Birmingham, Sandwell and Solihull Cardiac and Stroke Network South East London Cardiac & Stroke Network Sussex Heart Network North East London Cardiac and Stroke Network Cardiac and Stroke Networks in Lancashire and Cumbria Greater Manchester & Cheshire Cardiac Network South West London Cardiac Network Cheshire & Merseyside Cardiac Network North & East Yorkshire and Northern Lincolnshire Cardiac Network North Central London Cardiac & Stroke Network West Yorkshire Cardiac Network Anglia Stroke and Heart Network Peninsula Cardiac Managed Clinical Network South Central Cardiovascular Network Surrey Heart & Stroke Network Bedfordshire and Hertfordshire Heart and Stroke Network North Wales Black Country Cardiovascular Network Coventry & Warwickshire Cardiovascular Network Shropshire & Staffordshire Cardiac Network Essex Cardiac and Stroke Network North of England Cardiovascular Network Herefordshire and Worcestershire Cardiac Network South Wales Avon, Gloucestershire, Wiltshire & Somerset Cardiac and Stroke Network East Midlands Cardiac & Stroke Network North Trent Network of Cardiac Care Eleven networks have achieved the Heart Rhythm UK/BSH target of 130 total CRT implants per million North Trent are implanting at only half of the target rate. A number of other networks are well below average and even further below the target rate

20 PCTs/LHBs in the Network Code PCT/LHB Population South West London Cardiac Network 1,412,154 5A5 Kingston 160,436 5K9 Croydon 364,815 5LG Wandsworth 307,710 5M6 Richmond and Twickenham 187,527 5M7 Sutton and Merton 391,

21 Correcting Implant Rates for Age and Sex Calculating Need Most pacemakers are implanted for conduction system disease, which is predominantly a disease of the elderly. The graph shows the percentage of the population in 5 year age bands, and the percentage of pacemaker implants. Only 11% of the population are aged 70 or more, but they receive 76% of all pacemaker implants. Men also receive more pacemakers than women. Although the national average new implant rate is 528, it reaches more than 11,000 in men aged more than 90 (right). So the proportion of older people in a local population will strongly influence how many pacemakers need to be implanted. If we examine closely the age and sex distribution of the local population of a PCT (LHB in Wales) or Network, we can work out how many pacemakers we would EXPECT to see implanted, compared to the national average. The ratio of the local and national rate is called the Relative Need, and we calculate this for both pacemakers and ICDs. So, for example, in North East London the population is relatively young. Only 8% are aged 70 or more, compared to the national average of 11%. This means that this network doesn't need as many pacemaker implants relative to the nation as a whole. Their Relative Need for Pacing is calculated to be 80% of the national average. In contrast, Sussex has a more elderly population, with 16% aged 70 or over. Their Relative Need for Pacing is 140%

22 Using Relative Need We want to make a fair and valid comparison between PCTs/LHBs, Networks and the National Average. That means we should correct for relative need. So, for example if North London has a pacing rate of 480, and Sussex has a rate of 840, are they different? North London's adjusted rate is 480 divided by relative need (80%) = 600. Sussex's adjusted rate is 840 divided by 140% = 600. So the adjusted rates for these two areas are the same, despite the major apparent difference in their unadjusted rates. Implantable Defibrillators The diseases for which ICDs are implanted are not the same as for pacemakers, and tend to occur in slightly younger people. These diseases are principally ischaemic heart disease and cardiomyopathy. We therefore need to calculate a separate relative need factor for ICDs. The graph (right) of new ICD implant rate in 2010 and 2011 shows that ICDs are also predominantly implanted in older people. Unlike pacemakers, the ICD implant rate starts to decline over the age of 75. The influence of a local elderly population of need for ICDs will therefore still be present, but just slightly less in magnitude than for pacemakers. Sussex, for instance, has a relative ICD need of 138%

23 Relative Need for Pacemakers, ICDs and CRTs National new implant rates 2011: Pacemaker:.524. ICD:.76. CRT:.113. new implants new implants total implants A PCT with a relatively OLD population will need relatively MORE implants compared to a PCT with a young population, because the incidence of indications for pacing and ICD is higher in older people. Code PCT/LHB Relative Need for Pacing Required Rate to be comparable with national average Relative Need for ICD Required Rate to be comparable with national average Relative Need for CRT Required Rate to be comparable with national average South West London Cardiac Network 75% % 62 76% 86 5A5 Kingston 82% % 65 80% 91 5K9 Croydon 77% % 64 78% 89 5LG Wandsworth 55% % 52 58% 65 5M6 Richmond and Twickenham 86% % 68 84% 95 5M7 Sutton and Merton 82% % 65 81% 92 Note: "Required" implant rates are relative to the national average rate, but are corrected depending on the age and sex distribution of the local population. For Pacemakers, the required implant rate will be higher if the percentage of older people in the PCT is higher. For ICDs and CRTs, the same general rule applies, but the pattern is slightly different, because these devices have a different age/sex distribution. These relative rates will be used to correct the observed rates and produce a truer reflection of local implant rates vs. local need

24 Centres providing Device Implants to this Network Centres that implanted at least 10 devices in this network in 2011 Centre Pacemaker ICD CRT GEO St George's Hospital MAY Croydon University Hospital NHB Royal Brompton Hospital STM St Mary's Hospital Paddington KTH Kingston Hospital STH St Thomas' Hospital ANT St Anthony's Hospital UCL University College Hospital EPS Epsom Hospital HSC Harley Street Clinic HAM Hammersmith Hospital LBH London Bridge Hospital KCH King's College Hospital

25 10 Year Implant Trends Network v National New Pacemaker Implant Rate adjusted for age and sex of network population Pacemakers (national target: 700 new implants per million population) rate per million population National The pacing rate rose slightly and remains above the national average. 250 South West London Cardiac Network year 120 New ICD Implant Rate adjusted for age and sex of network population ICD (national target: 100 new implants per million population) rate per million population rate per million population year Total CRT Implant Rate adjusted for age and sex of network population National South West London Cardiac Network year National South West London Cardiac Network ICD rate rose to well above the national average. CRT (national target: 130 total implants per million population) CRT implant rate fell in 2011 but is consistent with the national target

26 Provider Hospitals: which hospitals serve which PCTs/LHBs? All implants in this cardiac network in 2011 PACEMAKERS PCT/LHB Implanting Centre Implants 5A5 KTH Kingston Hospital 46 Kingston GEO St George's Hospital 31 STH St Thomas' Hospital 7 ANT St Anthony's Hospital 7 NHB Royal Brompton Hospital 6 UCL University College Hospital 1 BFH Broomfield Hospital 1 EPS Epsom Hospital 1 HSC Harley Street Clinic 1 RSU Royal Surrey County Hospital 1 SPH St Peter's Hospital 1 5K9 MAY Croydon University Hospital 137 Croydon GEO St George's Hospital 20 LBH London Bridge Hospital 6 NHB Royal Brompton Hospital 5 ANT St Anthony's Hospital 5 STH St Thomas' Hospital 4 KCH King's College Hospital 4 UCL University College Hospital 3 RCH Royal Cornwall Hospital

27 5LG GEO St George's Hospital 76 Wandsworth STM St Mary's Hospital Paddington 17 STH St Thomas' Hospital 15 NHB Royal Brompton Hospital 12 KTH Kingston Hospital 3 WES Chelsea & Westminster Hospital 3 ANT St Anthony's Hospital 2 HAM Hammersmith Hospital 2 HSC Harley Street Clinic 2 KCH King's College Hospital 2 LBH London Bridge Hospital 2 FRM Frimley Park Hospital 1 UCL University College Hospital 1 MAY Croydon University Hospital 1 SPH St Peter's Hospital 1 ZZZ unknown hospital 1 5M6 STM St Mary's Hospital Paddington 39 Richmond and Twickenham NHB Royal Brompton Hospital 19 KTH Kingston Hospital 17 GEO St George's Hospital 16 ANT St Anthony's Hospital 9 HSC Harley Street Clinic 5 HAM Hammersmith Hospital 4 STH St Thomas' Hospital 3 HHW Wellington Hospital 1 CMH Central Middlesex Hospital 1 RFH Royal Free Hospital 1 5M7 GEO St George's Hospital 162 Sutton and Merton NHB Royal Brompton Hospital 22 EPS Epsom Hospital 18 KTH Kingston Hospital 9 ANT St Anthony's Hospital 7 STH St Thomas' Hospital 4 MAY Croydon University Hospital 4 SPH St Peter's Hospital 4 STM St Mary's Hospital Paddington 2 ESU East Surrey Hospital 1 HSC Harley Street Clinic 1 LBH London Bridge Hospital 1 NHH North Hampshire Hospital 1 RDE Royal Devon & Exeter Hospital

28 ICDs Implantable Cardioverter Defibrillators PCT/LHB Implanting Centre Implants 5A5 GEO St George's Hospital 14 Kingston NHB Royal Brompton Hospital 1 STH St Thomas' Hospital 1 UCL University College Hospital 1 STM St Mary's Hospital Paddington 1 5K9 GEO St George's Hospital 16 Croydon UCL University College Hospital 4 HH Harefield Hospital 2 KCH King's College Hospital 2 NHB Royal Brompton Hospital 1 5LG GEO St George's Hospital 15 Wandsworth NHB Royal Brompton Hospital 4 STH St Thomas' Hospital 4 HAM Hammersmith Hospital 2 BAL Barts and The London 1 STM St Mary's Hospital Paddington 1 5M6 NHB Royal Brompton Hospital 8 Richmond and Twickenham STM St Mary's Hospital Paddington 6 GEO St George's Hospital 4 HHW Wellington Hospital 2 UCL University College Hospital 1 HSC Harley Street Clinic 1 5M7 GEO St George's Hospital 42 Sutton and Merton NHB Royal Brompton Hospital 3 HH Harefield Hospital 1 HHW Wellington Hospital 1 UCL University College Hospital 1 BRI Bristol Royal Infirmary 1 SPH St Peter's Hospital 1 STM St Mary's Hospital Paddington

29 CRTs Cardiac Resynchronisation Therapy PCT/LHB Implanting Centre Implants 5A5 NHB Royal Brompton Hospital 13 Kingston GEO St George's Hospital 5 STH St Thomas' Hospital 2 HSC Harley Street Clinic 1 UCL University College Hospital 1 LBH London Bridge Hospital 1 SPH St Peter's Hospital 1 STM St Mary's Hospital Paddington 1 5K9 GEO St George's Hospital 5 Croydon NHB Royal Brompton Hospital 5 UCL University College Hospital 5 KCH King's College Hospital 2 STH St Thomas' Hospital 1 5LG GEO St George's Hospital 18 Wandsworth NHB Royal Brompton Hospital 8 STM St Mary's Hospital Paddington 3 STH St Thomas' Hospital 2 UCL University College Hospital 1 HAM Hammersmith Hospital 1 5M6 STM St Mary's Hospital Paddington 11 Richmond and Twickenham NHB Royal Brompton Hospital 7 GEO St George's Hospital 3 HAM Hammersmith Hospital 2 HSC Harley Street Clinic 1 UCL University College Hospital 1 SPH St Peter's Hospital 1 5M7 GEO St George's Hospital 27 Sutton and Merton NHB Royal Brompton Hospital 12 UCL University College Hospital

30 Geographical Location of Implants Pacemaker Implants Please note Mayday Hospital has been renamed Croydon University Hospital

31 Complex Implants (ICD and CRT)

32 Pacing Mode in this Network: Physiological vs Non-Physiological There is ample evidence that atrial-based pacing modes (also known as physiological pacing modes) improve patients quality of life, and may also prolong survival. NICE Guidance (TA88, 2005) has confirmed the desirability of physiological pacing when appropriate. 30 years ago all pacemakers were ventricular-based, i.e. the only part of the heart which was stimulated was the lower chambers. Increasingly, atrialbased (mainly dual chamber) pacing has replaced the ventricular modes, a trend which is beneficial to patients. It is not possible, or desirable, to completely eradicate ventricular pacing. Patients in permanent atrial fibrillation cannot benefit from atrial-based pacing, and this is a significant subgroup in the elderly. Mode % for this network % for England Atrial based pacing DDDR 69.1% 66.9% DDD 0.4% 2.4% AAIR % AAI % Other 0.1% 0.03% Ventricular based pacing VVIR 30.1% 29.9% VVI 0.3% 0.8% The proportion of physiological pacing in this network is very similar to the national average

33 Pacing Mode for New Implants by Centre Only implants in this network Mode DDDR DDD AAIR AAI Other physiological All Physiological VVIR VVI National 66.9% 2.4% 0.0% 0.0% 0.03% 69.3% 29.9% 0.8% This network 69.1% 0.4% 0.0% 0.0% 0.1% 69.7% 34.4% 0.5% St George's Hospital Croydon University Hospital Royal Brompton Hospital Kingston Hospital St Mary's Hospital Paddington St Thomas' Hospital St Anthony's Hospital Epsom Hospital 76.4% 1.0% 0.0% 0.0% 0.0% 77.4% 22.6% 0.0% 53.5% 0.0% 0.0% 0.0% 0.0% 53.5% 46.5% 0.0% 78.1% 0.0% 0.0% 0.0% 1.6% 79.7% 18.8% 1.6% 60.0% 0.0% 0.0% 0.0% 0.0% 60.0% 40.0% 0.0% 72.4% 0.0% 0.0% 0.0% 0.0% 72.4% 27.6% 0.0% 75.8% 0.0% 0.0% 0.0% 0.0% 75.8% 24.2% 0.0% 60.0% 0.0% 0.0% 0.0% 0.0% 60.0% 40.0% 0.0% 63.2% 0.0% 0.0% 0.0% 0.0% 63.2% 36.8% 0.0% use of physiological pacing is notably high at St George's and Brompton hospitals. the rate of physiological pacing is low at Croydon, Kingston and St Anthony's hospitals. Note: Pacing Mode is based on the maximum mode of which the device is capable, and not the programmed mode at the end of the procedure

34 Physiological Pacing in Sick Sinus Syndrome Only implants in this network There is ample evidence from major clinical trials and support from NICE guidelines (NICE Technology Appraisal 88, 2005) that use of ventricular pacing modes in patients with sick sinus syndrome can lead to poor outcomes, notably an increased incidence of atrial fibrillation and pacemaker syndrome. Pacing modes in sick sinus syndrome should be atrial based (i.e. dual chamber or atrial). The Western European average in 2005 was 92% atrial based pacing for SSS. In the UK the average was 81% in 2009, 84% in 2010 and 84% in Any percentage of ventricular based pacing greater than 10% has been shaded pink, and may be considered higher than desirable. A percentage greater than 20% is considered definitely too high and is shown in a shaded red box. Percentages greater than 50% are shown shaded black. Number of implants for Sick Sinus Syndrome % Atrial Based Pacing % Ventricular Based Pacing England 83.7% 16.3% This network 83.8% 16.2% St George's Hospital % 10.5% St Mary's Hospital Paddington % 4.8% Croydon University Hospital % 23.1% Kingston Hospital % 17.6% Physiological pacing rate for SSS is very high at St Mary's Hospital but lower than is desirable at Kingston and Croydon Hospitals. Note: any hospital in the network but not in this list did not code at least 10 implants as SSS. Note: for this analysis only ECG codes E1-E5 are used for SSS. Code E6 is excluded

35 ECG Indication for New Pacemaker Implants ECG Indication for all new implants in England 2011 Sick sinus syndrome 28% AF + HB/brady 22% Other 6% Complete heart block 21% Incomplete heart block 23% AF: atrial fibrillation HB: heart block Brady: bradycardia Complete HB Incomplete HB AF+ HB/brady Sick Sinus Syndrome Other National 21.3% 23.0% 22.2% 27.5% 5.9% This Network 22.0% 21.3% 27.4% 25.0% 4.3% St George's Hospital 24.7% 24.3% 20.5% 29.3% 1.3% Croydon University Hospital 16.3% 12.5% 46.2% 18.3% 6.7% Royal Brompton Hospital 25.0% 15.9% 29.5% 15.9% 13.6% St Mary's Hospital Paddington 16.7% 14.8% 27.8% 38.9% 1.9% Kingston Hospital 13.0% 34.8% 39.1% 10.9% 2.2% St Thomas' Hospital 17.9% 21.4% 21.4% 25.0% 14.3% Epsom Hospital 29.4% 35.3% 23.5% 11.8% 0.0% St Anthony's Hospital 17.6% 35.3% 17.6% 29.4% 0.0%

36 New Pacemaker Implant Rates corrected for Age and Sex Explanatory note: The "corrected rate (R), expressed as implants per million population, is calculated using the following formula: R A B. C x10 6 where A = number of new implants B = population C = relative need Population Need for Pacing New PM Implants Corrected New PM Implant Rate Deficit/ Excess compared to target rate of 700 ENGLAND 100% 526 This network 1,412,154 75% % 5A5 Kingston 160,436 82% % 5K9 Croydon 364,815 77% % 5LG Wandsworth 307,710 55% % 5M6 Richmond and Twickenham 187,527 86% % 5M7 Sutton and Merton 391,666 82% %

37 New ICD Implant Rates corrected for Age and Sex Population Need for ICD New ICD Implants Corrected New ICD Implant Rate Deficit/ Excess compared to target rate of 100 ENGLAND 100% 77 This network 1,412,154 81% % 5A5 Kingston 160,436 84% % 5K9 Croydon 364,815 83% % 5LG Wandsworth 307,710 67% % 5M6 Richmond and Twickenham 187,527 89% % 5M7 Sutton and Merton 391,666 85% % Note: values between 95% and 105% are not considered significantly different from the target rate so are in black text

38 New Implant Rate Maps

39 Pacemaker Implant Deficit in 2011 The table below shows how many extra pacemakers each PCT would need to commission to bring the implant rate up to the national recommended target rate for new pacemaker implants (700). If the value shown is zero, then the PCT is already commissioning enough devices to reach the target rate. Population Deficit/ Excess compared to target rate of 700 New Pacemaker Implant Deficit (number of devices) 5A5 Kingston 160,436-18% 20 5K9 Croydon 364,815-30% 78 5LG Wandsworth 307,710-11% 24 5M6 Richmond and Twickenham 187,527-17% 22 5M7 Sutton and Merton 391,666-14% 39 0 Kingston Croydon Wandsworth Richmond and Twickenham Sutton and Merton implant deficit

40 Conclusions The Network population is young so there is a relatively low need for pacing, particularly in Wandsworth where the need is only 75% of the national average. Across the whole network the need for pacing and ICDs is 19% less than the national average. Growth in both the PM and ICD implant rates bring them, respectively, above the national average and in line with the national target. A moderate fall in CRT rate still retains the Network at the national target rate for this device class. Croydon PCT appears to be an outlier for low implant rates within the Network. Data quality and completeness fields for administrative and basic clinical details are generally satifactory with some deficits, especially at London Bridge Hospital. However, for complex device fields there are major data deficits for all hospitals serving the Network, except Royal Brompton and St. George's Hospitals. Correction of these deficits will enhance the value of future audits. The use of physiological pacing modes is generally higher than the national average across the Network, although there is considerable variation between implanting centres. However, for sick sinus syndrome, higher than desirable rates of ventricular pacing are seen at three hospitals, notably Croydon and Kingston Hospitals - this is not compliant with NICE guidance. By contrast, commendably high rates of physiological pacing for this diagnosis are reported at St. Mary's Hospital, Paddington

Clinical Audit of Heart Rhythm Devices Pacemaker, ICD and CRT Herefordshire and Worcestershire Cardiac Network

Clinical Audit of Heart Rhythm Devices Pacemaker, ICD and CRT Herefordshire and Worcestershire Cardiac Network 20 Clinical Audit of Heart Rhythm Devices Pacemaker, ICD and CRT Herefordshire and Worcestershire Cardiac Network David Cunningham Senior Strategist, NICOR Morag Cunningham CRM Database Coordinator, NICOR

More information

Dorset Cardiac Network

Dorset Cardiac Network David Cunningham Director, Central Cardiac Audit Database Richard Charles Chairman, Network Device Survey Group Morag Cunningham CRM Database Coordinator, Central Cardiac Audit Database Adél de Lange Data

More information

Sussex Heart Network. David Cunningham Director, Central Cardiac Audit Database. Richard Charles Chairman, Network Device Survey Group

Sussex Heart Network. David Cunningham Director, Central Cardiac Audit Database. Richard Charles Chairman, Network Device Survey Group David Cunningham Director, Central Cardiac Audit Database Richard Charles Chairman, Network Device Survey Group Morag Cunningham CRM Database Coordinator, Central Cardiac Audit Database Adél de Lange Data

More information

Anglia Stroke and Heart Network

Anglia Stroke and Heart Network David Cunningham Director, Central Cardiac Audit Database Richard Charles Chairman, Network Device Survey Group Morag Cunningham CRM Database Coordinator, Central Cardiac Audit Database Adél de Lange Data

More information

Essex Cardiac and Stroke Network

Essex Cardiac and Stroke Network David Cunningham Director, Central Cardiac Audit Database Richard Charles Chairman, Network Device Survey Group Morag Cunningham CRM Database Coordinator, Central Cardiac Audit Database Adél de Lange Data

More information

Wales North Cardiac Network

Wales North Cardiac Network David Cunningham Director, Central Cardiac Audit Database Richard Charles Chairman, Network Device Survey Group Morag Cunningham CRM Database Coordinator, Central Cardiac Audit Database Adél de Lange Data

More information

Wales North Cardiac Network

Wales North Cardiac Network Wales North Cardiac Network David Cunningham Director, Central Cardiac Audit Database Richard Charles Chairman, Network Device Survey Group Morag Cunningham CRM Database Coordinator, Central Cardiac Audit

More information

Cheshire & Merseyside Cardiac Network

Cheshire & Merseyside Cardiac Network David Cunningham Director, Central Cardiac Audit Database Richard Charles Chairman, Network Device Survey Group Morag Cunningham CRM Database Coordinator, Central Cardiac Audit Database Adél de Lange Data

More information

East Midlands Cardiac and Stroke Network

East Midlands Cardiac and Stroke Network David Cunningham Director, Central Cardiac Audit Database Richard Charles Chairman, Network Device Survey Group Morag Cunningham CRM Database Coordinator, Central Cardiac Audit Database Adél de Lange Data

More information

North of England Cardiovascular Network

North of England Cardiovascular Network David Cunningham Director, Central Cardiac Audit Database Richard Charles Chairman, Network Device Survey Group Morag Cunningham CRM Database Coordinator, Central Cardiac Audit Database Adél de Lange Data

More information

Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT. East Anglia Local Area Team

Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT. East Anglia Local Area Team Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT East Anglia Local Area Team 2012 Acknowledgments is a partnership of clinicians, IT experts, statisticians, academics and managers which

More information

Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT. Bath, Gloucestershire, Swindon and Wiltshire Local Area Team

Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT. Bath, Gloucestershire, Swindon and Wiltshire Local Area Team Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT Bath, Gloucestershire, Swindon and Wiltshire Local Area Team 2012 Acknowledgments is a partnership of clinicians, IT experts, statisticians,

More information

Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT. Thames Valley Local Area Team

Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT. Thames Valley Local Area Team Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT Thames Valley Local Area Team 2012 Acknowledgments is a partnership of clinicians, IT experts, statisticians, academics and managers which

More information

The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert Albania. Algeria. Armenia. Austria. Belarus. Belgium. Bosnia & Herzegovina. Bulgaria. Croatia. Cyprus. Czech Republic Denmark. Egypt. Estonia. Finland. Former Yugoslav Republic of Macedonia. France. Georgia.

More information

Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT. Cheshire, Warrington and Wirral Local Area Team

Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT. Cheshire, Warrington and Wirral Local Area Team Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT Cheshire, Warrington and Wirral Local Area Team 2012 Acknowledgments is a partnership of clinicians, IT experts, statisticians, academics

More information

Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT. Merseyside Local Area Team

Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT. Merseyside Local Area Team Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT Merseyside Local Area Team 2012 Acknowledgments is a partnership of clinicians, IT experts, statisticians, academics and managers which

More information

The British Cardiovascular Society 2014 Workforce Survey. A report to the BCS October 2014

The British Cardiovascular Society 2014 Workforce Survey. A report to the BCS October 2014 The British Cardiovascular Society 2014 Workforce Survey A report to the BCS October 2014 Kevin Fox VP Clinical Standards, Andrew Wragg (Survey Clinical Lead), Gemma Cooper (BCS Office Lead for the Survey)

More information

Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT. Cumbria, Northumberland, Tyne and Wear Local Area Team

Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT. Cumbria, Northumberland, Tyne and Wear Local Area Team Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT Cumbria, Northumberland, Tyne and Wear Local Area Team 2012 Acknowledgments is a partnership of clinicians, IT experts, statisticians,

More information

The EHRA White Book 2009 The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

The EHRA White Book 2009 The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert Albania. Algeria. Armenia. Austria. Belarus. Belgium. Bosnia & Herzegovina. Bulgaria. Croatia. Cyprus. Czech Republic Denmark. Egypt. Estonia. Finland. Former Yugoslav Republic of Macedonia. France. Georgia.

More information

Quality care. Everywhere? An audit of prostate cancer services in the UK

Quality care. Everywhere? An audit of prostate cancer services in the UK Quality care. Everywhere? An audit of prostate cancer services in the UK Foreword Why should a man who lives in Essex receive worse care and support for prostate cancer than a man who comes from Manchester?

More information

Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT. North Yorkshire and Humber Local Area Team

Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT. North Yorkshire and Humber Local Area Team Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT North Yorkshire and Humber Local Area Team 2012 Acknowledgments is a partnership of clinicians, IT experts, statisticians, academics and

More information

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 HUNGARY WCPT COUNTRY PROFILE December 2017 HUNGARY HUNGARY NUMBERS WCPT Members Practising physical therapists 727 Total number of physical therapist members in your member organisation 4,000 Total number of practising

More information

The EHRA White Book 2010

The EHRA White Book 2010 Albania. Algeria. Armenia. Austria. Belarus. Belgium. Bosnia & Herzegovina. Bulgaria. Croatia Cyprus. Czech Republic. Denmark. Egypt. Estonia. Finland. Former Yugoslav Republic of Macedonia France. Georgia.

More information

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 SWEDEN WCPT COUNTRY PROFILE December 2017 SWEDEN SWEDEN NUMBERS WCPT Members Practising physical therapists 11,043 Total number of physical therapist members in your member organisation 17,906 Total number of

More information

WCPT COUNTRY PROFILE December 2017 SERBIA

WCPT COUNTRY PROFILE December 2017 SERBIA WCPT COUNTRY PROFILE December 2017 SERBIA SERBIA NUMBERS WCPT Members Practising physical therapists 622 Total number of physical therapist members in your member organisation 3,323 Total number of practising

More information

Smokefree Policies in Europe: Are we there yet?

Smokefree Policies in Europe: Are we there yet? Smokefree Policies in Europe: Are we there yet? 14 April 2015, 9:00 10:30am Rue de l Industrie 24, 1040 Brussels Permanent Partners: Temporary Partners: The research for the SFP Smokefree Map was partially

More information

Primary and secondary prevention of sudden cardiac death in emerging economies

Primary and secondary prevention of sudden cardiac death in emerging economies Primary and secondary prevention of sudden cardiac death in emerging economies Béla Merkely MD, PhD, DSc, FESC Heart Center Semmelweis University Budapest Common risk factors for sudden cardiac death Increasing

More information

UK bowel cancer care outcomes: A comparison with Europe

UK bowel cancer care outcomes: A comparison with Europe UK bowel cancer care outcomes: A comparison with Europe What is bowel cancer? Bowel cancer, which is also known as colorectal or colon cancer, is a cancer that affects either the colon or the rectum. The

More information

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10% % of reported measles cases WHO EpiBrief A report on the epidemiology of selected vaccine-preventable diseases in the European Region No. /17 This issue of WHO EpiBrief provides an overview of selected

More information

Alcohol-related harm in Europe and the WHO policy response

Alcohol-related harm in Europe and the WHO policy response Alcohol-related harm in Europe and the WHO policy response Lars Moller Programme Manager World Health Organization Regional Office for Europe Date of presentation NCD global monitoring framework: alcohol-related

More information

Where we stand in EFORT

Where we stand in EFORT Where we stand in EFORT Engaging with the new EU regulatory landscape for medical devices. Challenges & opportunities Brussel, Belgium April 6, 2018 Per Kjaersgaard-Andersen Associate Professor Section

More information

THE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures

THE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures THE CVD CHALLENGE IN NORTHERN IRELAND Together we can save lives and reduce NHS pressures The challenge of CVD continues today. Around 225,000 people in Northern Ireland live with the burden of cardiovascular

More information

European status report on alcohol and health Leadership, awareness and commitment

European status report on alcohol and health Leadership, awareness and commitment European status report on alcohol and health 2014 Leadership, awareness and commitment Leadership, awareness and commitment Background Strong leadership from national and local governments is essential

More information

Q1 What age are you?

Q1 What age are you? Q1 What age are you? Answered: 504 Skipped: 0 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 4.56% 23 3.77% 19 4.56% 23 6.15% 31 3.97% 20 6.55% 33 5.95% 30 6.75% 34 6.35% 32 4.37% 22 6.75% 34 5.56%

More information

HCPC registered Psychologists in the UK

HCPC registered Psychologists in the UK HCPC registered Psychologists in the UK Author: Hannah Farndon (Hannah.farndon@bps.org.uk) 1. Introduction This report provides the first information and analysis of UK psychologists registered with the

More information

European Status report on Alcohol and Health

European Status report on Alcohol and Health European Status report on Alcohol and Health Dr Lars Moller Regional Advisor a.i. WHO Regional Office for Europe Main killers in the WHO European Region Source: Preventing chronic diseases. A vital investment.

More information

Reflecting on ten years of progress in the fight against AIDS, TB and malaria

Reflecting on ten years of progress in the fight against AIDS, TB and malaria Reflecting on ten years of progress in the fight against AIDS, TB and malaria Michel Kazatchkine UN Secretary General s Special Envoy on HIV/AIDS in Eastern Europe and central Asia Ten years of progress:

More information

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe 21st Congress of the European Association of Dental Public Health 1 October 2016 Budapest

More information

LEBANON. WCPT COUNTRY PROFILE December 2018

LEBANON. WCPT COUNTRY PROFILE December 2018 LEBANON WCPT COUNTRY PROFILE December 2018 LEBANON NUMBERS 1600 1400 1200 1000 800 600 400 200 0 Physical therapists in the country Members in MO 1,480 1,480 Total PTs in country 800000 700000 600000 500000

More information

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA September 2017 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for Europe Marmorvej

More information

Engagement in language assessment / Regions of Europe

Engagement in language assessment / Regions of Europe Summary table: Engagement in language / Regions of This table lists the statistically significant differences in the engagement in activities by the respondents from different s of : If the word or appears

More information

DENMARK. WCPT COUNTRY PROFILE December 2018

DENMARK. WCPT COUNTRY PROFILE December 2018 DENMARK WCPT COUNTRY PROFILE December 2018 DENMARK NUMBERS 14000 12000 10000 8000 6000 4000 2000 0 Physical therapists in the country Members in MO 11,720 12,975 Total PTs in country 800000 700000 600000

More information

The cancer burden in the European Union and the European Region: the current situation and a way forward

The cancer burden in the European Union and the European Region: the current situation and a way forward The cancer burden in the European Union and the European Region: the current situation and a way forward Presented by Zsuzsanna Jakab WHO Regional Director for Europe Informal Meeting of Health Ministers

More information

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE 2018 2019 WINTER SEASON October 2018 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for

More information

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

Highlighting in the WHO European Region: Summary. No. 21(February 2012) No. 21(February 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European

More information

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences Media Release Embargoed 00.01 CET Monday 12 th March 2012 Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences Up to 70 percent of

More information

GERMANY. WCPT COUNTRY PROFILE December 2018

GERMANY. WCPT COUNTRY PROFILE December 2018 GERMANY WCPT COUNTRY PROFILE December 2018 GERMANY NUMBERS 160000 140000 120000 100000 80000 60000 40000 20000 0 Physical therapists in the country Members in MO 21,502 136,000 Total PTs in country 800000

More information

GRASP-AF- The National Picture. Dr Richard Healicon National Improvement Lead Ian Robson Senior Analyst NHS Improvement February 2012

GRASP-AF- The National Picture. Dr Richard Healicon National Improvement Lead Ian Robson Senior Analyst NHS Improvement February 2012 GRASP-AF- The National Picture Dr Richard Healicon National Improvement Lead Ian Robson Senior Analyst NHS Improvement February 2012 Outline AF and stroke Objective Management of stroke risk Stroke risk

More information

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Biology Report Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Introduction Tuberculosis is a serious disease caused by the bacterium Mycobacterium

More information

Summary. Primary care data. Week 49/2014. Season

Summary. Primary care data. Week 49/2014. Season Summary Week 49/2014 In week 49/2014, influenza activity remained low across the WHO European Region. Twenty countries reported sporadic influenza activity and nine reported increasing trends in consultations

More information

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010. Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010. WHO/Europe publishes a weekly electronic bulletin on influenza activity in the Region 1 and

More information

Table 6.1 Summary information for colorectal cancer in Ireland,

Table 6.1 Summary information for colorectal cancer in Ireland, 6 Colorectal cancer 6.1 Summary Colorectal cancer is the second most common cancer in Ireland (excluding non-melanoma skin cancer). It accounts for 12% of all malignant neoplasia in females and 15% in

More information

Table 7.1 Summary information for lung cancer in Ireland,

Table 7.1 Summary information for lung cancer in Ireland, 7 Lung cancer 7.1 Summary Lung cancer is the third most common cancer in Ireland, accounting for 15% of cancers in men and 9% in women, if non-melanoma skin cancer is excluded (table 7.1). Each year, approximately

More information

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

EURO POLIO PAGE Data as of 04 October 2005 (Week 38) World Health Organization Regional Office for Europe EURO POLIO PAGE Data as of 04 October 2005 (Week 38) Vaccine-preventable Diseases and Immunization programme, Division of Technical Support website:

More information

Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous)

Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous) Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous) 25 th Conference of the OIE Regional Commission for Europe 17 th to 21 st September 2012, Fleesensee Germany

More information

Highlighting in the WHO European Region:

Highlighting in the WHO European Region: No. 23(April 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European

More information

Q3 Statistical Report 2017

Q3 Statistical Report 2017 Q Statistical Report 07 Summary Overall Quarter Observations During this quarter, the Helpline saw a steady increase in number calls rising from 7 in July to 7 in September. We had an unprecedented 94

More information

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance No. 17 (September 2011) A monthly publication on vaccine preventable diseases and immunization data and analysis Issue 15, April 2011 Highlighting in the WHO European Region: measles outbreaks rubella

More information

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe Jürgen Rehm 1-4 Kevin D. Shield 1,2,3 1) Centre for Addiction and Mental Health, Toronto, Canada 2) University of Toronto, Canada

More information

Access to treatment and disease burden

Access to treatment and disease burden Access to treatment and disease burden Robert Flisiak Department of Infectious Diseases and Hepatology Medical University in Białystok, Poland Moulin de Vernègues, 27-29 August 2015 Disclosures Advisor

More information

Principal Treatment Centres What do the data say for childhood cancer?

Principal Treatment Centres What do the data say for childhood cancer? Principal Treatment Centres What do the data say for childhood cancer? Charles Stiller National Registry of Childhood Tumours (NRCT) Childhood Cancer Research Group (CCRG) Children s Cancer and Leukaemia

More information

A Global perspective on Heart Failure: What needs to change? Martin R Cowie London, United Kingdom

A Global perspective on Heart Failure: What needs to change? Martin R Cowie London, United Kingdom A Global perspective on Heart Failure: What needs to change? Martin R Cowie London, United Kingdom Global perspective on heart failure: what needs to change? Martin R Cowie Professor of Cardiology National

More information

Registered childcare providers and places in England, 30 September October 2004

Registered childcare providers and places in England, 30 September October 2004 Registered childcare providers and places in England, 30 September 2004. 21 October 2004 Contents: Childcare statistics About this publication Registered childcare providers and places in England, by Ofsted

More information

The Constitution of the British Association for Chronic Fatigue Syndrome/ME (BACME) CONTENTS. Name of the Organisation. 2. Aims and Objectives

The Constitution of the British Association for Chronic Fatigue Syndrome/ME (BACME) CONTENTS. Name of the Organisation. 2. Aims and Objectives The Constitution of the British Association for Chronic Fatigue Syndrome/ME (BACME) October 2013 CONTENTS Name of the Organisation 1. History 2. Aims and Objectives 3. Membership of BACME 4. BACME executive

More information

11 Melanoma of the skin

11 Melanoma of the skin 11 Melanoma of the skin 11.1 Summary Melanoma of the skin is the ninth most common cancer in Ireland, accounting for 2.4 of all malignant neoplasia in men and 4.2 in women, if non-melanoma skin cancers

More information

Table 9.1 Summary information for stomach cancer in Ireland,

Table 9.1 Summary information for stomach cancer in Ireland, 9 Stomach cancer 9.1 Summary Stomach cancer ranks seventh in terms of the most common cancers in Ireland, accounting for 4.1% of all malignant neoplasia in men and 2.8% in women, when non-melanoma skin

More information

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013 Men & Health Promotion @ Work Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013 Difference can make a Difference Mens health: State of mens health Use of services Role of the

More information

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

Department of Biological Standardisation OMCL Network & Healthcare (DBO) Department of Biological Standardisation OMCL Network & Healthcare (DBO) Implementation of Pathogen Reduction Technologies for Blood Components for Transfusion: Updated Table 2009-2010 COUNCIL OF EUROPE

More information

Overview of drug-induced deaths in Europe - What does the data tell us?

Overview of drug-induced deaths in Europe - What does the data tell us? Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug

More information

The health economic landscape of cancer in Europe

The health economic landscape of cancer in Europe 1 Approval number The health economic landscape of cancer in Europe Bengt Jönsson, Professor Emeritus of Health Economics Stockholm School of Economics 2 Disclaimer This presentation was developed by Professor

More information

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Introduction Tuberculosis is a serious disease caused by the bacterium Mycobacterium tuberculosis.

More information

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information PARALLELISM AND THE LEGITIMACY GAP 1 Appendix A Country Information PARALLELISM AND THE LEGITIMACY GAP 2 Table A.1 Sample size by country 2006 2008 2010 Austria 2405 2255 0 Belgium 1798 1760 1704 Bulgaria

More information

Overall survival: 1 st line therapy

Overall survival: 1 st line therapy 1 3 Overall survival: 1 st line therapy 2-year OS phase III studies mm Prices per month of oncology medicin Bloomberg Business weekly 26 Feb 2015 Presented By Veena Shankaran at 2016 ASCO Annual Meeting

More information

Development of Palliative Care services in different countries

Development of Palliative Care services in different countries Development of Palliative Care services in different countries Nicoleta Mitrea EONS leadership summit, 2017 Disclosure speaker Do you have any interest to declare? No, I don t have any interest to declare.

More information

National Institute on Alcohol Abuse and Alcoholism. Environmental Approaches

National Institute on Alcohol Abuse and Alcoholism. Environmental Approaches Environmental Approaches Consumption of 10+ and 21+ Drinks on an Occasion At Least Once in the Past Year, 2013 30 25 20 15 10+ drinks 15 25 10+ drinks 16 25 10 5 0 21+ drinks 3 2 21+ drinks 18-20 21-24

More information

Preventing the uptake of smoking by children

Preventing the uptake of smoking by children Action on Smoking and Health (ASH) ASLEF Association of Directors of Adult Social Services Association of Pschoanalytic Psychotherapy in the NHS Association of Public Health Observatories Asthma UK Bedfordshire

More information

Real Life, Real PD Survey

Real Life, Real PD Survey Real Life, Real PD Survey Final Pan-European Survey Results Survey Objectives The survey was carried out to provide insights into the realities of living with PD and to highlight some of the symptoms of

More information

Cross Border Genetic Testing for Rare Diseases

Cross Border Genetic Testing for Rare Diseases Cross Border Genetic Testing for Rare Diseases EUCERD Joint Action WP8 Helena Kääriäinen National Institute for Health an Welfare, Helsinki, Finland Starting point Possibilities and demand for genetic

More information

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Public Health Public health is the science and art of preventing disease, prolonging

More information

European Association of Dental Public Health Prevention of Oral Cancer

European Association of Dental Public Health Prevention of Oral Cancer European Association of Dental Public Health Prevention of Oral Cancer Special Interest Working Group Thursday 14th November 2013 PD Dr. Katrin Hertrampf, MPH Dr. Colwyn Jones, Associate Editor Malta 2013

More information

Summary. 10 The 2007 ESPAD Report

Summary. 10 The 2007 ESPAD Report The main purpose of the European School Survey Project on Alcohol and Other Drugs (ESPAD) is to collect comparable data on substance use among 15 16 year-old European students in order to monitor trends

More information

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke «L Europe de la santé au service des patients» 13-14 October 2008 - Institut Pasteur Paris Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke Simona Giampaoli National Centre of

More information

Dental public health epidemiology programme Oral health survey of five-year-old and 12-year-old children attending special support schools 2014

Dental public health epidemiology programme Oral health survey of five-year-old and 12-year-old children attending special support schools 2014 Dental public health epidemiology programme Oral health survey of five-year-old and 12-year-old children attending special support schools 2014 A report on the prevalence and severity of dental decay Oral

More information

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods Annual Epidemiological Report for 2015 Trichinellosis Key facts In 2015, a total of 156 confirmed cases of trichinellosis was reported from 29 EU/EEA countries. The overall notification rate was 0.03 cases

More information

real-time AQ data 2007 and plans for 2008

real-time AQ data 2007 and plans for 2008 real-time AQ data 2007 and plans for 2008 Tim Haigh - project manager Information Resources http://www.eea.europa.eu/maps/ozone/map/ Where is all the data coming from? EEA NRT Database 4000 2000 700 EEA

More information

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006 World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006 WHO Regional Office for Europe Vaccine-preventable Diseases and Immunization programme,

More information

Quality Standards for the Implantation of Cardiac Rhythm Management Devices. Pan- London Arrhythmia Project Group. Version 3 (18 th July 2011)

Quality Standards for the Implantation of Cardiac Rhythm Management Devices. Pan- London Arrhythmia Project Group. Version 3 (18 th July 2011) Quality Standards for the Implantation of Cardiac Rhythm Management Devices Pan- London Arrhythmia Project Group Version 3 (18 th July 2011) 1 Standards for Implantation of Permanent Pacemakers (including

More information

Prevention of Oral Cancer Special Interest Working Group

Prevention of Oral Cancer Special Interest Working Group Prevention of Oral Cancer Special Interest Working Group Dr Colwyn Jones, Consultant in Dental Public Health, NHS Health Scotland, 1 South Gyle Crescent, Edinburgh EH12 9EB, Scotland. colwyn.jones@nhs.net

More information

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY JACEK MOSKALEWICZ INSTITUTE OF PSCHIATRY AND NEUROLOGY WARSAW, POLAND THIRD EUROPEAN CONFERENCE ON ALCOHOL AND LAW ENFORCEMENT,

More information

NHS ENGLAND BOARD PAPER

NHS ENGLAND BOARD PAPER NHS ENGLAND BOARD PAPER Paper: PB.15.12.2016/04 Title: Taking the cancer strategy forward: programme update Lead Director: Professor Sir Bruce Keogh, National Medical Director Cally Palmer, National Cancer

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Review of TA88; Dual-chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome and/or atrioventricular block

More information

Percutaneous Mitral Valve Therapies

Percutaneous Mitral Valve Therapies Percutaneous Mitral Valve Therapies Jeffrey J. Popma, MD Director, Interventional Cardiology Clinical Services Beth Israel Deaconess Medical Center Associate Professor of Medicine Harvard Medical School

More information

Rheumatoid Arthritis Disease Burden and Access to Treatment

Rheumatoid Arthritis Disease Burden and Access to Treatment Berlin, April 2012 Rheumatoid Arthritis Disease Burden and Access to Treatment Gisela Kobelt, PhD Visiting Professor, Lund University (Sweden) President, European Health Economics (France) Disclaimers

More information